🇺🇸 FDA
Patent

US 8895722

Splice-region antisense composition and method

granted A61KA61K38/00A61P

Quick answer

US patent 8895722 (Splice-region antisense composition and method) held by Sarepta Therapeutics, Inc. expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61P, A61P13/08, A61P17/00